Terms: = Liver cancer AND CDK6, MGC59692, 1021, Q00534, ENSG00000105810, PLSTIRE AND Prognosis
28 results:
1. Identifying Proliferative Hepatocellular Carcinoma at Pretreatment CT: Implications for Therapeutic Outcomes after Transarterial Chemoembolization.
Bao Y; Li JX; Zhou P; Tong Y; Wang LZ; Chang DH; Cai WW; Wen L; Liu J; Xiao YD
Radiology; 2023 Aug; 308(2):e230457. PubMed ID: 37642572
[TBL] [Abstract] [Full Text] [Related]
2. OTUD7B deubiquitinates and stabilizes YAP1 to upregulate NUAK2 expression, thus accelerating gastric cancer procession.
Guo Z; Guo L
Dig Liver Dis; 2024 Feb; 56(2):352-362. PubMed ID: 37429790
[TBL] [Abstract] [Full Text] [Related]
3. Lipophagy-related gene RAB7A is involved in immune regulation and malignant progression in hepatocellular carcinoma.
Liu Y; Ma J; Wang X; Liu P; Cai C; Han Y; Zeng S; Feng Z; Shen H
Comput Biol Med; 2023 May; 158():106862. PubMed ID: 37044053
[TBL] [Abstract] [Full Text] [Related]
4. Tumor-suppressive role of microfibrillar associated protein 4 and its clinical significance as prognostic factor and diagnostic biomarker in hepatocellular carcinoma.
Li J; Wang J; Liu Z; Guo H; Wei X; Wei Q; Zheng S; Xu X
J Cancer Res Ther; 2022 Dec; 18(7):1919-1925. PubMed ID: 36647950
[TBL] [Abstract] [Full Text] [Related]
5. Silencing of KNTC1 inhibits hepatocellular carcinoma cells progression via suppressing PI3K/Akt pathway.
Tong H; Liu X; Peng C; Shen B; Zhu Z
Cell Signal; 2023 Jan; 101():110498. PubMed ID: 36273753
[TBL] [Abstract] [Full Text] [Related]
6. ANKFN1 plays both protumorigenic and metastatic roles in hepatocellular carcinoma.
Wang Y; Zhang Y; Mi J; Jiang C; Wang Q; Li X; Zhao M; Geng Z; Song X; Li J; Zuo L; Ge S; Zhang Z; Wen H; Wang Z; Su F
Oncogene; 2022 Jul; 41(29):3680-3693. PubMed ID: 35725908
[TBL] [Abstract] [Full Text] [Related]
7. Descriptive analysis of incidental and operable gallbladder carcinoma cases: a UK centre experience.
Karunaratne S; Gamage A; Bagwan IN
Pathologica; 2022 Apr; 114(2):138-145. PubMed ID: 35481564
[TBL] [Abstract] [Full Text] [Related]
8. ZC3H15 Correlates with a Poor prognosis and Tumor Progression in Melanoma.
Li Q; Hou J; Guo C; Zhang Y; Liu L; Hu H; Shi S; Ji Y; Guo L; Shi Y; Liu Y; Cui H
Biomed Res Int; 2021; 2021():8305299. PubMed ID: 34988227
[TBL] [Abstract] [Full Text] [Related]
9. (20S) Ginsenoside Rh2 Exerts Its Anti-Tumor Effect by Disrupting the HSP90A-Cdc37 System in Human liver cancer Cells.
Chen C; Wang YS; Zhang ET; Li GA; Liu WY; Li Y; Jin YH
Int J Mol Sci; 2021 Dec; 22(23):. PubMed ID: 34884975
[TBL] [Abstract] [Full Text] [Related]
10. Cell division cycle associated 8: A novel diagnostic and prognostic biomarker for hepatocellular carcinoma.
Cui XH; Peng QJ; Li RZ; Lyu XJ; Zhu CF; Qin XH
J Cell Mol Med; 2021 Dec; 25(24):11097-11112. PubMed ID: 34741389
[TBL] [Abstract] [Full Text] [Related]
11. LINC00205, a YY1-modulated lncRNA, serves as a sponge for miR-26a-5p facilitating the proliferation of hepatocellular carcinoma cells by elevating cdk6.
Cheng T; Yao Y; Zhang S; Zhang XN; Zhang AH; Yang W; Hou CZ
Eur Rev Med Pharmacol Sci; 2021 Oct; 25(20):6208-6219. PubMed ID: 34730201
[TBL] [Abstract] [Full Text] [Related]
12. eIF6 promotes the malignant progression of human hepatocellular carcinoma via the mTOR signaling pathway.
Sun L; Liu S; Wang X; Zheng X; Chen Y; Shen H
J Transl Med; 2021 May; 19(1):216. PubMed ID: 34016142
[TBL] [Abstract] [Full Text] [Related]
13. miR-186 Represses Proliferation, Migration, Invasion, and EMT of Hepatocellular Carcinoma via Directly Targeting cdk6.
Lu J; Zhao Z; Ma Y
Oncol Res; 2020 Dec; 28(5):509-518. PubMed ID: 32698940
[TBL] [Abstract] [Full Text] [Related]
14. Prognostic Role of Time to Surgery in Hepatocellular Carcinoma at Barcelona Clinic liver cancer Stage 0-A.
Wei M; Chen S; Li J; Li B; Shen J; Peng Z; Zhou Q; Zou Y; He X; Li S; Li D; Peng B; Lai J; Peng S; Qin B; Kuang M
Ann Surg Oncol; 2020 Oct; 27(10):3740-3753. PubMed ID: 32424586
[TBL] [Abstract] [Full Text] [Related]
15. Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis.
Mao R; Qiu Y; He JS; Tan JY; Li XH; Liang J; Shen J; Zhu LR; Chen Y; Iacucci M; Ng SC; Ghosh S; Chen MH
Lancet Gastroenterol Hepatol; 2020 Jul; 5(7):667-678. PubMed ID: 32405603
[TBL] [Abstract] [Full Text] [Related]
16. Molecular Profiling of Hepatocellular Carcinoma Using Circulating Cell-Free DNA.
Kaseb AO; Sánchez NS; Sen S; Kelley RK; Tan B; Bocobo AG; Lim KH; Abdel-Wahab R; Uemura M; Pestana RC; Qiao W; Xiao L; Morris J; Amin HM; Hassan MM; Rashid A; Banks KC; Lanman RB; Talasaz A; Mills-Shaw KR; George B; Haque A; Raghav KPS; Wolff RA; Yao JC; Meric-Bernstam F; Ikeda S; Kurzrock R
Clin Cancer Res; 2019 Oct; 25(20):6107-6118. PubMed ID: 31363003
[TBL] [Abstract] [Full Text] [Related]
17. Predictors of ribociclib-mediated antitumour effects in native and sorafenib-resistant human hepatocellular carcinoma cells.
Reiter FP; Denk G; Ziesch A; Ofner A; Wimmer R; Hohenester S; Schiergens TS; Spampatti M; Ye L; Itzel T; Munker S; Teufel A; Gerbes AL; Mayerle J; De Toni EN
Cell Oncol (Dordr); 2019 Oct; 42(5):705-715. PubMed ID: 31250364
[TBL] [Abstract] [Full Text] [Related]
18. MiR-34a overexpression enhances the inhibitory effect of doxorubicin on HepG2 cells.
Zheng SZ; Sun P; Wang JP; Liu Y; Gong W; Liu J
World J Gastroenterol; 2019 Jun; 25(22):2752-2762. PubMed ID: 31235998
[TBL] [Abstract] [Full Text] [Related]
19. Rs2303428 of MSH2 Is Associated with Hepatocellular Carcinoma prognosis in a Chinese Population.
Zhu X; Wang Z; Qiu X; Wang W; Bei C; Tan C; Qin L; Ren Y; Tan S
DNA Cell Biol; 2018 Jul; 37(7):634-641. PubMed ID: 29874113
[TBL] [Abstract] [Full Text] [Related]
20. MART-10 represses cholangiocarcinoma cell growth and high vitamin D receptor expression indicates better prognosis for cholangiocarcinoma.
Chiang KC; Yeh TS; Huang CC; Chang YC; Juang HH; Cheng CT; Pang JS; Hsu JT; Takano M; Chen TC; Kittaka A; Hsiao M; Yeh CN
Sci Rep; 2017 Mar; 7():43773. PubMed ID: 28256614
[TBL] [Abstract] [Full Text] [Related]
[Next]
